Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivo Mueller

Showing results (361-370 of 420) with videos related to

Pageof 42
Sort By:
Plos Neglected Tropical Diseases|August 27, 2021
Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensitiesCristian Koepfli, Wang Nguitragool, Anne Cristine Gomes de Almeida, et al.
Gates Open Research|June 8, 2019
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria eliminationBryan Greenhouse, Jennifer Daily, Caterina Guinovart, et al.
The Journal of Biological Chemistry|February 12, 2025
Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivaxJaison D Sa, Lucas Krauss, Lauren Smith, et al.
The New England Journal of Medicine|December 10, 2008
A trial of combination antimalarial therapies in children from Papua New GuineaHarin A Karunajeewa, Ivo Mueller, Michele Senn, et al.
Pathogens (Basel, Switzerland)|September 28, 2023
Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD ScreeningAyleen Kosasih, Robert James, Nguyen Hoang Chau, et al.
Plos Medicine|April 6, 2012
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialNicolas Senn, Patricia Rarau, Danielle I Stanisic, et al.
Plos One|October 3, 2012
The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malariaLinda Reiling, Jack S Richards, Freya J I Fowkes, et al.
The Journal of Infectious Diseases|October 11, 2025
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalizationRebeca Linhares Abreu Netto, Catherine Chen, Victor Irungu Mwangi, et al.
Plos Medicine|October 28, 2015
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelLeanne J Robinson, Rahel Wampfler, Inoni Betuela, et al.
Cellular Microbiology|April 10, 2019
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytesJulie Healer, Wilson Wong, Jennifer K Thompson, et al.
Pageof 42

Showing results (361-370 of 420) with videos related to

Sort By:
Pageof 42
Plos Neglected Tropical Diseases|August 27, 2021
Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensitiesCristian Koepfli, Wang Nguitragool, Anne Cristine Gomes de Almeida, et al.
Gates Open Research|June 8, 2019
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria eliminationBryan Greenhouse, Jennifer Daily, Caterina Guinovart, et al.
The Journal of Biological Chemistry|February 12, 2025
Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivaxJaison D Sa, Lucas Krauss, Lauren Smith, et al.
The New England Journal of Medicine|December 10, 2008
A trial of combination antimalarial therapies in children from Papua New GuineaHarin A Karunajeewa, Ivo Mueller, Michele Senn, et al.
Pathogens (Basel, Switzerland)|September 28, 2023
Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD ScreeningAyleen Kosasih, Robert James, Nguyen Hoang Chau, et al.
Plos Medicine|April 6, 2012
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialNicolas Senn, Patricia Rarau, Danielle I Stanisic, et al.
Plos One|October 3, 2012
The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malariaLinda Reiling, Jack S Richards, Freya J I Fowkes, et al.
The Journal of Infectious Diseases|October 11, 2025
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalizationRebeca Linhares Abreu Netto, Catherine Chen, Victor Irungu Mwangi, et al.
Plos Medicine|October 28, 2015
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelLeanne J Robinson, Rahel Wampfler, Inoni Betuela, et al.
Cellular Microbiology|April 10, 2019
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytesJulie Healer, Wilson Wong, Jennifer K Thompson, et al.
Pageof 42